AbCellera Biologics Inc. (ABCL) /
The revenue of AbCellera Biologics Inc. over the past 7 years
Chart AbCellera Biologics Inc.: revenue, fiscal 2019–2025 Open the chart →AbCellera Biologics Inc. reported revenue of $75.13M in fiscal 2025, the latest fiscal year on file. In fiscal 2019 it was $11.61M — up 547% over 6 years. Year over year, revenue rose 4 times and fell twice. In these years the highest was $485.42M in fiscal 2022. The largest one-year move was in fiscal 2020: up 1908%, from $11.61M to $233.16M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $75.13M |
| 2024ended Dec 31, 2024 | $28.83M |
| 2023ended Dec 31, 2023 | $38.02M |
| 2022ended Dec 31, 2022 | $485.42M |
| 2021ended Dec 31, 2021 | $375.2M |
| 2020ended Dec 31, 2020 | $233.16M |
| 2019ended Dec 31, 2019 | $11.61M |
Fiscal years as AbCellera Biologics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AbCellera Biologics Inc.
- The profitability of AbCellera Biologics Inc.
- The cash flow of AbCellera Biologics Inc.
- The debt of AbCellera Biologics Inc.
- All of AbCellera Biologics Inc.'s financials, charted
Companies of a similar size
- GEOThe GEO Group, Inc.
- RUSHARUSH ENTERPRISES, INC.
- EQPTEquipmentShare.com Inc
- SLMSLM Corp
- ACMRACM Research, Inc.
Not investment advice. This page shows what AbCellera Biologics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.